|
MTAP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.193800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.782400E-01 |
| Normal-vs-Stage2 |
6.392300E-02 |
| Normal-vs-Stage3 |
3.874800E-01 |
| Normal-vs-Stage4 |
8.761200E-01 |
| Stage1-vs-Stage2 |
7.761800E-02 |
| Stage1-vs-Stage3 |
5.074400E-01 |
| Stage1-vs-Stage4 |
8.353200E-01 |
| Stage2-vs-Stage3 |
2.153200E-01 |
| Stage2-vs-Stage4 |
9.266300E-02 |
| Stage3-vs-Stage4 |
4.944800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.791000E-01 |
| Normal-vs-AfricanAmerican |
3.639200E-01 |
| Normal-vs-Asian |
5.298600E-01 |
| Caucasian-vs-AfricanAmerican |
2.671800E-01 |
| Caucasian-vs-Asian |
7.511800E-01 |
| AfricanAmerican-vs-Asian |
1.994010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.025000E-01 |
| Normal-vs-Female |
7.339600E-01 |
| Male-vs-Female |
6.854000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.609600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.280400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.914800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.139220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.430000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.765200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.354400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.409400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.185200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.331000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.113400E-01 |
| Classical-VS-Follicular |
4.61759996905897E-09 |
| Classical-VS-Other |
4.069800E-01 |
| Classical-VS-Normal |
5.090400E-01 |
| Tall-VS-Follicular |
5.56629999999281E-05 |
| Tall-VS-Other |
2.480800E-01 |
| Tall-VS-Normal |
3.333000E-01 |
| Follicular-VS-Other |
2.627000E-01 |
| Follicular-VS-Normal |
1.218580E-04 |
| Other-VS-Normal |
4.882600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.203800E-02 |
| Normal-vs-N1 |
3.485600E-01 |
| N0-vs-N1 |
6.632200E-01 |
|
|
